Bio-Rad Laboratories, Inc. (BIO)
280.03
-1.79
(-0.64%)
USD |
NYSE |
May 19, 15:17
Bio-Rad Laboratories Research and Development Expense (Quarterly) : 62.90M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 117.00M |
| Bruker Corp. | 101.30M |
| Azenta, Inc. | 9.433M |
| Harvard Bioscience, Inc. | 2.326M |
| Revvity, Inc. | 57.89M |